AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces

What You Should Know: 

– Cleerly, a leader in cardiovascular imaging, and Cardiac Care Alliance, a prominent figure in value-based cardiovascular care solutions, today announced a strategic partnership aimed at significantly enhancing cardiovascular care delivery. 

– The collaboration will see the integration of Cleerly’s advanced AI-powered coronary artery assessment technology into Cardiac Care Alliance’s extensive cardiovascular care network. The initiative is set to launch initially with cardiology practices in Texas, with ambitions for broader implementation.

Optimizing Cardiac Pathways with Advanced AI Technology

A key objective of this partnership is to refine the diagnostic journey for patients with cardiovascular symptoms. Cardiac Care Alliance will incorporate Cleerly’s Artificial Intelligence–Quantitative Coronary Tomography (AI-QCT) technology into its offerings for payers and practices. The goal is to ensure that symptomatic patients, when appropriate, undergo Cleerly’s noninvasive assessment prior to considering cardiac catheterization procedures. This strategic sequencing aims to direct the right patients to the catheterization laboratory while helping others avoid unnecessary invasive testing and the associated costs.

Cleerly’s AI-QCT technology provides a comprehensive and standardized assessment of coronary artery disease based on noninvasive Cardiac Computed Tomography Angiography (CCTA). Studies have demonstrated its high accuracy in evaluating the presence, extent, and composition of coronary atherosclerotic plaque, reportedly superior to consensus readings from Level 3 Expert Physician Readers¹.

“We’re always seeking ways to expand access to life-saving heart care, and by combining our networks, both organizations can reach more providers and patients,” said Prakash Patel, MD, CEO and Chairman of Cardiac Care Alliance. “This partnership represents our commitment to providing solutions that are both clinically effective and economically sustainable. Cardiovascular disease currently costs the US healthcare system approximately $233 billion annually, and is the most costly chronic condition in the US, roughly 11% of total healthcare expenditures². Delivering care that can provide early detection and guide clinical decisions to the right interventions to improve outcomes and reduce unnecessary costs, are critical to addressing this growing healthcare challenge.”

Phased Rollout 

The partnership will initially launch with select cardiology practices in Texas, serving as a foundation for future expansion. Both Cleerly and Cardiac Care Alliance are optimistic that this integrated approach will set a new standard in cardiovascular care, ultimately benefiting patients by improving outcomes and making care more sustainable.